Table 2.
Shape homogeneity of subcutaneous tumors formed by AML cell lines
| Tumor no. | Kg‐1 | Kg‐1a | OCL‐AML‐5 | ME‐1 | OCI‐AML3 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Control | Polo | Control | Polo | Control | Polo | Control | Polo | Control | Polo | |
| 1 | 1.62 | 1.33 | 2.45 | 1.34 | 1.24 | 1.27 | 1.75 | 1.2 | 1.35 | 1.12 |
| 2 | 1.89 | 1.15 | 1.13 | 1.11 | 1.45 | 1.35 | 1.56 | 1.11 | 1.12 | 1.22 |
| 3 | 1.52 | 1.28 | 1.88 | 1.22 | 2.01 | 1.11 | 1.35 | 1.19 | 0 | 1.31 |
| 4 | 2.34 | 1.38 | 1.76 | 1.31 | 1.86 | 1.48 | 1.48 | 1.35 | 1.73 | 1.13 |
| 5 | 1.52 | 1.21 | 0 | 1.18 | 1.25 | 1.56 | 2.22 | 1.51 | 2.34 | 1.15 |
| 6 | 0 | 1.24 | 1.66 | 1.25 | 1.44 | 1.21 | 1.91 | 1.17 | 1.54 | 1.21 |
| 7 | 2.17 | 1.17 | 1.54 | 1.22 | 1.95 | 1.33 | 2.21 | 1.13 | 0 | 1.29 |
| 8 | 2.16 | 1.24 | 2.22 | 1.19 | 2.05 | 1.44 | 1.65 | 1.28 | 2.14 | 1.32 |
Abbreviations: Control, solvent control; Polo, Poloxamer 407.